Evidence map›Paper›PMID 29095919›Full record

ArticlePloS one2017

Raldh1 promotes adiposity during adolescence independently of retinal signaling.

Di Yang, Charles R Krois, Priscilla Huang, Jinshan Wang, Jin Min, Hong Sik Yoo, Yinghua Deng, Joseph L Napoli

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Di YangGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Charles R KroisGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Priscilla HuangGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Jinshan WangGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Jin MinGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Hong Sik YooGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Yinghua DengGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.
Joseph L NapoliGraduate Program in Metabolic Biology, Nutritional Sciences and Toxicology, University of California, Berkeley, California, United States of America.ORCID http://orcid.org/0000-0003-3223-4752
University of California, Berkeley · US

Funding

Rdh10 and retinoic acid effects on differentiationR01DK112754 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI NAPOLI, JOSEPH L · 2017 to 2021
$1.9M
Retinoid HomeostasisR01DK102014 · NIDDK · UNIVERSITY OF CALIFORNIA BERKELEY · PI NAPOLI, JOSEPH L · 2015 to 2019
$1.7M
NIDDK NIH HHS R01 DK102014NIDDK NIH HHS R01 DK112754
6 · The paper itself

Abstract

All-trans-retinoic acid (RA) inhibits adipogenesis in established preadipocyte cell lines. Dosing pharmacological amounts of RA reduces weight gain in mice fed a high-fat diet, i.e. counteracts diet-induced obesity (DIO). The aldehyde dehydrogenase Raldh1 (Aldh1a1) functions as one of three enzymes that converts the retinol metabolite retinal into RA, and one of many proteins that contribute to RA homeostasis. Female Raldh1-ablated mice resist DIO. This phenotype contrasts with ablations of other enzymes and binding-proteins that maintain RA homeostasis, which gain adiposity. The phenotype observed prompted the conclusion that loss of Raldh1 causes an increase in adipose tissue retinal, and therefore, retinal functions independently of RA to prevent DIO. A second deduction proposed that low nM concentrations of RA stimulate adipogenesis, in contrast to higher concentrations. Using peer-reviewed LC/MS/MS assays developed and validated for quantifying tissue RA and retinal, we show that endogenous retinal and RA concentrations in adipose tissues from Raldh1-null mice do not correlate with the phenotype. Moreover, male Raldh1-null mice resist weight gain regardless of dietary fat content. Resistance to weight gain occurs during adolescence in both sexes. We show that RA concentrations as low as 1 nM, i.e. in the sub-physiological range, impair adipogenesis of embryonic fibroblasts from wild-type mice. Embryonic fibroblasts from Raldh1-null mice resist differentiating into adipocytes, but retain ability to generate RA. These fibroblasts remain sensitive to an RA receptor pan-agonist, and are not affected by an RA receptor pan-antagonist. Thus, the data do not support the hypothesis that retinal itself represses weight gain and adipogenesis independently of RA. Instead, the data indicate that Raldh1 functions as a retinal and atRA-independent promoter of adiposity during adolescence, and enhances adiposity through pre-adipocyte cell autonomous actions.

Indexed as

AdipositySignal TransductionAldehyde Dehydrogenase 1 FamilyAnimalsIsoenzymesMiceRetinaldehydeRetinal DehydrogenaseAldehyde Dehydrogenase 1 FamilyALDH1A1 protein, mouseIsoenzymesRetinaldehydeRetinal Dehydrogenase

Identifiers

PMID29095919
PMCPMC5667840
OpenAlexW2765903255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.